Deuterium Capital Management’s Johnson & Johnson JNJ Stock Holding History

Deuterium Capital Management’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-4,801	Closed	-$848K	–	97
2022 Q4	$848K	Buy	4,801 +2,783	+138%	+$481K	2.25%	8
2022 Q3	$330K	Sell	2,018 -2,002	-50%	-$339K	1.38%	15
2022 Q2	$714K	Hold	4,020	–	–	2.42%	9
2022 Q1	$712K	Buy	+4,020	New	+$684K	0.92%	20

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Deuterium Capital Management's JNJ Position: Q1 2023 in Review

Deuterium Capital Management sold out of Johnson & Johnson (JNJ) in Q1 2023, closing a stake of 4,801 shares — an estimated $848K sold.

Deuterium Capital Management first reported a position in JNJ in Q1 2022 and held it in 4 quarters. The position peaked at $848K in Q4 2022. 3,729 funds tracked by Wall St. Rank hold JNJ as of Q1 2023.

Deuterium Capital Management reported no remaining Johnson & Johnson position as of Q1 2023 after selling out during the quarter.
Deuterium Capital Management sold 4,801 Johnson & Johnson shares in Q1 2023, an estimated $848K.
Deuterium Capital Management first reported a position in Johnson & Johnson in Q1 2022 and held it in 4 quarters.
Deuterium Capital Management's Johnson & Johnson position peaked at $848K in Q4 2022.
3,729 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2023.

Based on Deuterium Capital Management's 13F filing for Q1 2023, filed 12 May 2023.